His scientific interests lie mostly in Cancer research, Cancer, Internal medicine, Wound healing and Genetics. David Thomas has researched Cancer research in several fields, including Carcinogenesis, Cellular differentiation, Immunology and In vivo. His studies in Cancer integrate themes in fields like Young adult, Mutation, Germline mutation and Bioinformatics.
His Germline mutation research integrates issues from Model organism, Hippo signaling pathway, MST1 and WWTR1, YAP1. His research integrates issues of Endocrinology, Downregulation and upregulation, Surgery and Oncology in his study of Internal medicine. His Wound healing research is multidisciplinary, relying on both Fibroblast, Epidermal growth factor, Pharmacology and Pathology.
David Thomas focuses on Electronic engineering, Internal medicine, Cancer, Cancer research and Pathology. His work deals with themes such as Time domain, Electrical impedance, Fault, Electrical engineering and Electric power system, which intersect with Electronic engineering. His Fault study combines topics from a wide range of disciplines, such as Power and Transient.
His Internal medicine research incorporates elements of Endocrinology, Surgery and Oncology. His Cancer research is multidisciplinary, incorporating elements of Germline mutation, Sarcoma and Bioinformatics. David Thomas does research in Cancer research, focusing on Osteosarcoma specifically.
David Thomas mostly deals with Cancer, Internal medicine, Oncology, Electronic engineering and Sarcoma. David Thomas combines subjects such as Germline, Germline mutation, Bioinformatics and Genomics with his study of Cancer. His research on Internal medicine frequently connects to adjacent areas such as Li–Fraumeni syndrome.
His research on Electronic engineering also deals with topics like
His primary scientific interests are in Cancer, Genome, Cancer research, Clinical trial and Internal medicine. His Cancer study combines topics in areas such as Mutation, Germline mutation, Bioinformatics, Young adult and Immunology. His Genome research includes themes of Precision medicine, Disease and Medical genetics.
David Thomas works in the field of Cancer research, namely Osteosarcoma. His Clinical trial research incorporates elements of Giant-cell tumor of bone, Medical physics and Soft tissue. The concepts of his Internal medicine study are interwoven with issues in Exome sequencing, Surgery, Oncology and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The effects of diversity on business performance: Report of the diversity research network
Thomas Kochan;Katerina Bezrukova;Robin Ely;Susan Jackson.
The Hippo pathway and human cancer
Kieran F. Harvey;Xiaomeng Zhang;Xiaomeng Zhang;David M. Thomas;David M. Thomas.
Nature Reviews Cancer (2013)
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Allan D. Kirk;David M. Harlan;Nicholas N. Armstrong;Thomas A. Davis.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Translational biology of osteosarcoma
Maya Kansara;Michele W. Teng;Mark J. Smyth;David M. Thomas.
Nature Reviews Cancer (2014)
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
David Thomas;Robert Henshaw;Keith M Skubitz;Sant Chawla.
Lancet Oncology (2010)
Analytical formulation for the shielding effectiveness of enclosures with apertures
M.P. Robinson;T.M. Benson;C. Christopoulos;J.F. Dawson.
IEEE Transactions on Electromagnetic Compatibility (1998)
The distinctive biology of cancer in adolescents and young adults
Archie Bleyer;Ronald Barr;Brandon Hayes-Lattin;David Thomas.
Nature Reviews Cancer (2008)
Levels of Matrix Metalloproteases in Bladder Cancer Correlate with Tumor Grade and Invasion
Bernard Davies;Jonathan Waxman;Harpret Wasan;Paul Abel.
Cancer Research (1993)
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
Sant Chawla;Robert Henshaw;Leanne Seeger;Edwin Choy.
Lancet Oncology (2013)
Effective dose from cone beam CT examinations in dentistry
J. Roberts;Nicholas Drage;J. Davies;David William Thomas.
British Journal of Radiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: